Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline, and fluvoxamine. I. Social interactions

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 1-2, 1997, Pages 119-125

  Cutler, M G ^a   Rodgers, R J ^b   Jackson, J E ^a,b  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Antidepressants; Anxiolytics; Chlordiazepoxide Maprotiline; Fluvoxamin e; Mice; Social Behavior

Indexed keywords

CHLORDIAZEPOXIDE; FLUVOXAMINE; MAPROTILINE;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FLIGHT; IMMOBILIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

ADRENERGIC UPTAKE INHIBITORS; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHLORDIAZEPOXIDE; DRUG EVALUATION, PRECLINICAL; FLUVOXAMINE; MALE; MAPROTILINE; MICE; MICE, INBRED STRAINS; SEROTONIN UPTAKE INHIBITORS; SOCIAL BEHAVIOR;

ANIMALIA;

EID: 0030992093     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00135-9     Document Type: Article

References (53)

1. Alder, T.; Morinan, S. Strain differences in behavioral responses in murine models of anxiety. Br. J. Pharmacol. 106:45; 1992.
2. D'Amoto, F. R.; Cabib, S. Chronic exposure to a novel odor increases pup vocalizations, maternal care and alters dopaminergic functioning in developing mice. Behav. Neural. Biol. 48:197-205; 1987.
3. Ballenger, J. D. Pharmacological treatment of panic disorder. In: DenBoer J. A.; Sitsen J. M., eds. Handbook of depression and anxiety. New York: Marcel Dekker; 1994:275-289.
4. Blanchard, R. J.; Shepherd, J. K.; Rodgers, R. J.; Magee, L.; Blanchard D. C. Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine. Psychopharmacology 110:245-253; 1993.
5. Bodnoff, S. R.; Curanyi-Cadotte, B.; Aitken, D. H.; Quirion, R.; Meaney, M. J. The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology 95:298-302; 1988.
6. Brain, P. F.; Nastiti, K.; Benton D. 'Anxiety'in laboratory rodents: A brief review of some recent behavioral developments. Behavioral Processes 25:71-80; 1991.
7. Cai, B.; Matsumoto, K.; Ohta, H.; Watabe, H. Biphasic effects of typical antidepressants and mianserin, an atypical antidepressant, on aggressive behavior in socially isolated mice. Pharmacol. Biochem. Behav. 44:519-525; 1993.
8. Claassen, V. Review of the animal pharmacology and pharmacokinetics of fluvoxamine. Br. J. Clin. Pharmacol. 15:3498-3558; 1993.
9. Cole, J. C.; Davies, J. M. Antidepressant drugs. In: Freedman, A. M., Kaplan, H. I., eds. Comprehensive textbook of psychiatry. Baltimore: Williams and Wilkins; 1967:1263-1275.
10. Costall, B.; Jones, B. J.; Kelly, M. E.; Naylor, R. J.; Tomkins, D. M. Exploration of mice in a black and white test box: Validation as a model of anxiety. Pharmacol. Biochem. Behav. 32:777-785; 1989.
11. Cutler, M. G.; Dixon A. K. Effects of ipsapirone on the behavior of mice during social encounters. Neuropharmacology 27:1039-1944; 1988.
12. Cutler, M. G. Anxiolytic drugs: does ethopharmacological analysis indicate commonalities in their mode of action? In: Cooper S. J.; Hendrie C. A., eds. Ethology and psychopharmacology. Chichester: John Wiley and Sons; 1994:45-58.
13. Cutler, M. G.; Rodgers, R. J.; Jackson J. E. Behavioral effects in mice of subchronic treatment with buspirone, ardansetron and tianeptine. I. Social Interaction. Pharmacol. Biochem. Behav., in press.
14. DenBoer, J. A.; Westenberg, H. G. M.; Kamerbeek, W. D. J.; Verhoeven W. M. A.; Kahn, R. S. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. Int. Clin. Psychopharmacology 2:21-32; 1987.
15. Dixon, A. K.; Fisch, H. U.; McAllister, K. H. Ethopharmacology: A biological approach to the study of drug-induced changes in behavior. Adv. Stud. Behav. 19:171-204; 1990.
16. Duncan, M. J.; Lister, R. G.; Eckard, M. J.; Linnoila, M. Behavioral interactions of fluoxetine and other g-hydroxytroptamine uptake inhibitors with ethanol in tests of anxiety, locomotion and exploration. Psychopharmacology 96:528-533; 1988.
17. Everill, B.; Brain P. F.; Rustana, A.; Mos, J.; Olivier, B. Ethoexperimental analysis of the impact of chlordiazepoxide (CDP) on social interactions in three strains of mice. Behav. Proc. 25:55-67; 1991.
18. File, S.E. The use of social interaction as a method for detecting anxiolytic-like activity of chlordiazepoxide-like drugs. J. Neurosci. Methods 2:219-238; 1980.
19. Filteau, M. J.; Baruch, P.; Lapierre, Y. D.; Bakish D.; Blanchard A. SSRIs in anxious-agitated depression: a post hoc analysis of 279 patients. Int. Clin. Psychopharmacol. 10:51-54; 1995.
20. Fontana, D. J.; Commissaris, R. L. Effects of acute and chronic imipramine administration in the rat: a potential 'animal model' for the study of panic disorder? Psychopharmacology 95:147-150; 1988.
21. Fontana, D. J.; Carbary, T. J.; Commissaris, R. L. Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat. Psychopharmacology 98:157-162; 1989.
22. 3 receptor antagonist, BRL 46470, on the behavior of mice. Neuropharmacology 31:207-213; 1992.
23. Gao, B.; Cutler, M. G. Effects of imipramine, mianserin and phenelzine on social behavior in mice. Neuropharmacology 33: 813-824; 1994.
24. Griebel, G.; Blanchard, D.; Agnes, R. S.; Blanchard, R. J. Differential modulation of antipredator defensive behavior in Swiss- Webster mice following acute or chronic administration of imipramine and fluoxetine. Psychopharmacology 120:55-66; 1995.
25. Handley, S. L.; McBlane, J. W. Opposite effects of fluoxetine in two animal models of anxiety. Br. J. Pharmacol. 107:446; 1992.
26. Hijzen, T. H.; Houtzager, S. W. J.; Joordens, R. J. E.; Olivier, B.; Slangen, J. L. Predictive value of the potentiated startle response as a behavioral model for anxiolytic drugs. Psychopharmacology 118:150-154; 1995.
27. Hoehn-Saric, R.; McLeod, D. R. Depression and anxiety: is there a common etiology: In: DenBoer, J. A.; Sitsen, A., eds., Handbook of depression and anxiety. New York: Marcel-Dekker; 1994: 119-168.
28. Hyttel, J. Comparative pharmacology of selective serotonin reuptake inhibitors (SSRIs) Nord. J. Psychiatry 47(Suppl 30): 5-12; 1993.
29. Kalynchuk, L.; Beck C. H. M. Behavioral analysis of diazepam- induced memory deficits: Evidence for sedation-like effects. Psychopharmacology 106:297-302; 1992.
30. Mason, P.; Skinner J.; Luttinger, D. Two tests in rats for antianxiety effect of clinically anxiety attenuating antidepressants. Psychopharmacology 92:30-34; 1987.
31. Miczek, K. A. The psychopharmacology of aggression. In: Iversen, L. L.; Iversen, S. D.; Snyder, S. S.; eds. Handbook of psychopharmacology, vol. 19. New York: Plenum; 1987:183-328.
32. Miczek, K. A.; Donat, P. Brain 5-HT system and inhibition of aggressive behavior. In: Bevon, P.; Cools, A. R.; eds.; Behavioral pharmacology of 5-HT. L. E. A., N. J.; 1989:117-144.
33. Mitchell, P. J.; Fletcher, A.; Redfer, P. H. Isantidepressantefficacy revealed by drug-induced changes in rat behavior exhibited during social interaction? Neurosci. Biobehav. Rev. 15:539-544; 1991.
34. Mitchell, P. J.; Redfern, P. H. Acute and chronic antidepressant drug treatment induce opposite effects in the social behavior of rats. J. Psychopharmacology 6:241-257; 1992.
35. Monleon, S.; D'Aquila, P.; Parra, A.; Simon V. M.; Brain P. F.; Willner, P. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology 117:453-457; 1995.
36. Mos, J.; Olivier, B.; van der Poel, A. M. Modulatory actions of benzodiazepine receptor ligands on agonistic behavior. Physiol. Behav. 41:265-278; 1987.
37. Nutt, D. J. Anxiety and its therapy today and tomorrow. In: Briely, M.; File, S. E.; eds.; New concepts in anxiety. London: MacMillan; 1991:1-12.
38. Nutt, D. J.,; Lawson, C. Panic attacks: A neurochemical overview of models and mechanisms. Br. J. Psychiat. 160:165-178; 1992.
39. Nystrom, C.; Halstrom, T. Comparison between a serotonin and noradrenaline reuptake blocker in the treatment of depressed outpatients. A cross-over study. Acta Psychiatr. Scand. 75:377-382; 1987.
40. Pinder, R. M.,; Brogden, R. N.; Speight, T. M.; Avery, B. S. Maprotiline: A review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs 13:321-352; 1977.
41. Reich J. The epidemiology of anxiety. J. Nerv. Ment. Dis. 174:129-136; 1986.
42. Rickels, K.; Downing, R.; Schweizer, E.; Hassman, H. Antidepressants for the treatment of generalized anxiety disorder. Arch. Gen. Psychiat. 50:884-895; 1993.
43. Rodgers, R. J.; Waters A. J. Benzodiazepines and their antagonists: A pharmacoethological analysis with particular reference to effects on "aggression." Neurosci. Biobehav. Rev. 9:21-35; 1985.
44. 3antagonists and benzodiazepines: the comparative behavior pharmacology. Chichester: Wiley; 1991:195-231.
45. Rodgers, R. J.; Cutler, M. G.; Jackson, J. E. Behavioral effects in mice of subchronic chlordiazepoxide, maprotiline and fluvoxamine. II. The elevated plus-maze. Pharmacol. Biochem. Behav., in press.
46. Sheehan, D. V. The tricyclic antidepressants in the treatment of anxiety and panic disorders. Psychosomatics 27:10-16; 1986.
47. 3 antagonists and benzodiazepines: the comparative behavioral pharmacology. Chichester: Wiley; 1991:159-164.
48. Tyrer, P.; Tyrer, J. Antidepressive drugs for the treatment of anxiety disorders and vice versa. In: DenBoer, J. A.; Sitsen, A.; eds.; Handbook of Depression and Anxiety. New York: Marcel- Dekker; 1994:497-514.
49. De Vry, J.; Benz, U.; Schreiber, R.; Traber, J. Shock-induced ultrasonic vocalization in young adult rats: A model for testing putative anti-anxiety drugs. Eur. J. Pharmacol. 249:331-339; 1993.
50. Westenberg, H. G. M.; DenBoer, J. A. The neuropharmacology of anxiety: A review of the role of serotonin. In: DenBoer, J. A.; Sitsen, J. M. A.; eds.; Handbook of depression and anxiety. New York: Marcel Dekker; 1994:497-514.
51. Wilde, M. I.; Plosker, G. L.; Benfield, P. Fluvoxamine. An updated review of its pharmacology and therapeutic use in depressive illness. Drugs 46:895-924; 1993.
52. Willner, P. Animal models of depression. In: Willner P.; ed.; Behavioral models in psychopharmacology: Theoretical, industrial and chemical perspectives. Cambridge; Cambridge University Press, 1991:91-125.
53. Young, R.; Johnson, D. N. A fully automated light/dark apparatus used for comparing anxiolytic drugs. Pharmacol. Biochem. Behav. 40:739-743; 1991.